1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Israel >
  5. Hyperion Therapeutics Acquires Andromeda Biotech

M&A Deal Summary

Hyperion Therapeutics Acquires Andromeda Biotech

On June 12, 2014, Hyperion Therapeutics acquired life science company Andromeda Biotech for 13M USD

Acquisition Highlights
  • This is Hyperion Therapeutics’ 1st transaction in the Life Science sector.
  • This is Hyperion Therapeutics’ largest (disclosed) transaction.
  • This is Hyperion Therapeutics’ 1st transaction in Israel.

M&A Deal Summary
Date 2014-06-12
Target Andromeda Biotech
Sector Life Science
Buyer(s) Hyperion Therapeutics
Deal Type Add-on Acquisition
Deal Value 13M USD

Target

Andromeda Biotech

Yavne, Israel
Andromeda Biotech Ltd. is a biopharmaceutical company.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Hyperion Therapeutics

Brisbane, California, United States
Category Company
Founded 2006
Sector Life Science
DESCRIPTION

Hyperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Israel M&A 1 of 1
Year: 2014 M&A 1 of 1
Size (of disclosed) 1 of 1
Mergr

Solution for

Product

Company

Legal